Literature DB >> 17531015

Thoughts on the complex relationship between gastroesophageal reflux disease and eosinophilic esophagitis.

Stuart Jon Spechler1, Robert M Genta, Rhonda F Souza.   

Abstract

Recent data suggest that the interaction between gastroesophageal reflux disease (GERD) and eosinophilic esophagitis can be complex, and that the notion of establishing a clear distinction between the two disorders may be too simplistic. There are at least four situations in which GERD might be associated with esophageal eosinophils: (a) GERD causes esophageal injury that results in a mild eosinophilic infiltration, (b) GERD and eosinophilic esophagitis coexist but are unrelated, (c) eosinophilic esophagitis contributes to or causes GERD, or (d) GERD contributes to or causes eosinophilic esophagitis. The high frequency of GERD described in adult patients with eosinophilic esophagitis suggests that there may be more than a chance association between the two disorders. This report discusses potential mechanisms for the complex interaction between GERD and eosinophilic esophagitis. We hope that this information will serve as a conceptual basis for future studies on the relationship between the two disorders. Whereas there are a number of plausible mechanisms whereby GERD might contribute to the accumulation of eosinophils in the esophageal epithelium, it seems prudent to recommend a clinical trial of proton pump inhibitor (PPI) therapy even when the diagnosis of eosinophilic esophagitis seems clear-cut. Furthermore, we suggest that a favorable response to PPI therapy does not preclude a diagnosis of eosinophilic esophagitis.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17531015     DOI: 10.1111/j.1572-0241.2007.01179.x

Source DB:  PubMed          Journal:  Am J Gastroenterol        ISSN: 0002-9270            Impact factor:   10.864


  109 in total

1.  52-year-old woman with dysphagia.

Authors:  Sahil Khanna; Amit Noheria; Charles H Rohren
Journal:  Mayo Clin Proc       Date:  2010-08       Impact factor: 7.616

2.  Advances in GERD: Current Developments in the Management of Acid-Related GI Disorders.

Authors: 
Journal:  Gastroenterol Hepatol (N Y)       Date:  2010-03

3.  Curious elements of esophageal foreign body impaction and eosinophilic esophagitis.

Authors:  J Christie Heller; Stephen Freeman; Glenn T Furuta
Journal:  Gastroenterol Hepatol (N Y)       Date:  2009-12

4.  Diagnoses of eosinophilic esophagitis in children who underwent foreign body retrieval of coins.

Authors:  Nicole Jordan; Robbyn Sockolow; Debra Beneck; Aeri Moon
Journal:  Gastroenterol Hepatol (N Y)       Date:  2009-12

Review 5.  Diagnosis and management of eosinophilic esophagitis.

Authors:  Evan S Dellon
Journal:  Clin Gastroenterol Hepatol       Date:  2012-06-19       Impact factor: 11.382

6.  Diagnostic utility of major basic protein, eotaxin-3, and leukotriene enzyme staining in eosinophilic esophagitis.

Authors:  Evan S Dellon; Xiaoxin Chen; C Ryan Miller; John T Woosley; Nicholas J Shaheen
Journal:  Am J Gastroenterol       Date:  2012-07-10       Impact factor: 10.864

Review 7.  Management of proton pump inhibitor responsive-esophageal eosinophilia and eosinophilic esophagitis: controversies in treatment approaches.

Authors:  Bharati Kochar; Evan S Dellon
Journal:  Expert Rev Gastroenterol Hepatol       Date:  2015-09-12       Impact factor: 3.869

8.  Dissociation between symptoms and histological severity in pediatric eosinophilic esophagitis.

Authors:  Scott Pentiuk; Phillip E Putnam; Margaret H Collins; Marc E Rothenberg
Journal:  J Pediatr Gastroenterol Nutr       Date:  2009-02       Impact factor: 2.839

9.  Effect of proton pump inhibitor on esophageal eosinophilia.

Authors:  Shauna Schroeder; Kelley E Capocelli; Joanne C Masterson; Rachel Harris; Cheryl Protheroe; James J Lee; Glenn T Furuta
Journal:  J Pediatr Gastroenterol Nutr       Date:  2013-02       Impact factor: 2.839

10.  Eosinophilic esophagitis: interactions with gastroesophageal reflux disease.

Authors:  Edaire Cheng; Rhonda F Souza; Stuart Jon Spechler
Journal:  Gastroenterol Clin North Am       Date:  2014-03-24       Impact factor: 3.806

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.